Skip to main content

Table 2 A List of 45 representative genes significantly down-regulated in week 8 topiramate group a

From: Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction

Gene symbol

Gene name

Week 8 TPM

  

FC ± SD b

P Value c

FDR d

Cell adhesion / Motion

CDC2L2

Cell division cycle 2-like 2

−1.39 ± 0.07

1.10 × 10−5

2.64 × 10−4

CDC42EP2

CDC42 effector protein (Rho GTPase binding) 2

−2.01 ± 0.19

1.00 × 10−6

5.07 × 10−5

EMILIN2

Elastin microfibril interfacer 2

−1.41 ± 0.05

<1.00 × 10−6

<1.00 × 10−5

JAK3

Janus kinase 3 (a protein tyrosine kinase, leukocyte)

−1.68 ± 0.11

1.00 × 10−6

5.07 × 10−5

TUBB2C

Tubulin, beta 2C

−1.39 ± 0.06

2.00 × 10−6

8.22 × 10−5

Nervous system development and function / synaptic plasticity

ADAT1

Adenosine deaminase, tRNA-specific 1

−1.61 ± 0.08

<1.00 × 10−6

<1.00 × 10−5

CIRBP

Cold inducible RNA binding protein

−1.74 ± 0.13

1.00 × 10−6

5.07 × 10−5

DGCR14

3-phosphoinositide dependent protein kinase-1

−1.45 ± 0.04

<1.00 × 10−6

<1.00 × 10−5

FKBP4

FK506 binding protein 4, 59 kDa

−1.49 ± 0.10

6.00 × 10−6

1.72 × 10−4

NAPA

N-ethylmaleimide-sensitive factor attachment protein, alpha

−2.04 ± 0.21

1.00 × 10−6

5.07 × 10−5

P2RX1

Purinergic receptor P2X, ligand-gated ion channel, 1

−1.72 ± 0.13

2.00 × 10−6

8.22 × 10−5

PRKACA

Solute carrier family 1 (glial high affinity glutamate transporter), member 3

−1.69 ± 0.15

1.10 × 10−5

2.64 × 10−4

SHC1

SHC (Src homology 2 domain containing) transforming protein 1

−1.23 ± 0.04

3.00 × 10−6

1.09 × 10−4

TRIM8

Tripartite motif-containing 8

−1.45 ± 0.06

4.00 × 10−6

1.31 × 10−4

Signaling transduction

ARHGEF2

Rho/rac guanine nucleotide exchange factor (GEF) 2

−1.62 ± 0.11

2.00 × 10−6

8.22 × 10−5

BCR

Breakpoint cluster region

−1.43 ± 0.06

<1.00 × 10−6

<1.00 × 10−5

GRINA

Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1

−2.49 ± 0.28

<1.00 × 10−6

<1.00 × 10−5

LIMK2

LIM domain kinase 2

−3.05 ± 0.44

4.00 × 10−6

1.31 × 10−4

PHPT1

Phosphohistidine phosphatase 1

−1.33 ± 0.06

7.00 × 10−6

1.92 × 10−4

PLCB2

Phospholipase C, beta 2

−1.93 ± 0.13

<1.00 × 10−6

<1.00 × 10−5

RHOT2

Ras homolog gene family, member T2

−1.46 ± 0.05

<1.00 × 10−6

<1.00 × 10−5

Ubiquitination / Intracellular protein transport

AP2A1

Adaptor-related protein complex 2, alpha 1 subunit

−2.04 ± 0.20

1.10 × 10−5

2.64 × 10−4

NPEPL1

Aminopeptidase-like 1

−1.26 ± 0.03

<1.00 × 10−6

<1.00 × 10−5

SHARPIN

SHANK-associated RH domain interactor

−2.13 ± 0.26

1.00 × 10−5

2.53 × 10−4

TRAPPC5

Trafficking protein particle complex 5

−1.58 ± 0.11

6.00 × 10−6

1.72 × 10−4

UBE2M

Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)

−1.70 ± 0.12

1.00 × 10−6

5.07 × 10−5

UBXN6

UBX domain protein 6

−2.40 ± 0.29

2.00 × 10−6

8.22 × 10−5

USP4

Ubiquitin specific peptidase 4 (proto-oncogene)

−1.46 ± 0.06

2.00 × 10−6

8.22 × 10−5

WBP2

WW domain binding protein 2

−1.85 ± 0.18

4.00 × 10−6

1.31 × 10−4

Mitochondrial function / metabolism and energy pathways

ATAD3B

ATPase family, AAA domain containing 3B

−1.47 ± 0.07

<1.00 × 10−6

<1.00 × 10−5

B4GALT3

UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3

−1.26 ± 0.04

1.00 × 10−6

5.07 × 10−5

COASY

Coenzyme A synthase

−1.29 ± 0.06

1.20 × 10−5

2.79 × 10−4

COX5B

Cytochrome c oxidase subunit Vb

−1.44 ± 0.09

1.20 × 10−5

2.79 × 10−4

GANAB

Glucosidase, alpha; neutral AB

−1.63 ± 0.08

<1.00 × 10−6

<1.00 × 10−5

MRPL37

Mitochondrial ribosomal protein L37

−1.30 ± 0.04

<1.00 × 10−6

<1.00 × 10−5

NAGK

N-acetylglucosamine kinase

−1.30 ± 0.05

4.00 × 10−6

1.31 × 10−4

NDUFV3

NADH dehydrogenase (ubiquinone) flavoprotein 3, 10 kDa

−1.63 ± 0.08

<1.00 × 10−6

<1.00 × 10−5

PFKL

Phosphofructokinase, liver

−1.53 ± 0.10

3.00 × 10−6

1.09 × 10−4

UROD

Uroporphyrinogen decarboxylase

−1.35 ± 0.06

5.00 × 10−6

1.54 × 10−4

Immune system function

CISH

Cytokine inducible SH2-containing protein

−1.34 ± 0.05

1.00 × 10−6

5.07 × 10−5

HLA-E

Major histocompatibility complex, class I, E

−1.25 ± 0.04

<1.00 × 10−6

<1.00 × 10−5

JMJD3

Jumonji domain containing 3, histone lysine demethylase

−2.03 ± 0.16

<1.00 × 10−6

<1.00 × 10−5

MSRB2

Methionine sulfoxide reductase B2

−1.68 ± 0.13

2.00 × 10−6

8.22 × 10−5

OAS1

2′,5′-oligoadenylate synthetase 1, 40/46 kDa

−1.84 ± 0.15

1.00 × 10−6

5.07 × 10−5

TAPBP

TAP binding protein (tapasin)

−1.60 ± 0.06

<1.00 × 10−6

<1.00 × 10−5

  1. aGenes are selected from a total of 62 down-regulated genes with Bonferroni-corrected P Values < 0.05 (i.e., 0.05/3698 genes = 1.35 × 10−5).
  2. bFC, denoting fold change, is defined as the ratio of the expression values of Positive Responders over Negative Responders; SD, standard deviation.
  3. cP Value was calculated using the ordinary Student’s t test for each gene.
  4. dFDR, denoting false discovery rate, was estimated by the Benjamini-Hochberg (BH) method.